Keymed Biosciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 18, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	8,985	13,586	14,267	9,651	-	-
Market Cap Growth	-17.71%	-4.77%	47.83%	-	-	-
Enterprise Value	7,024	10,725	10,424	15,170	-	-
Last Close Price	32.60	49.10	51.00	34.50	-	-
PS Ratio	97.17	34.83	126.12	71.30	-	-
PB Ratio	3.17	4.13	3.78	2.16	-	-
P/TBV Ratio	3.30	4.13	3.78	2.15	-	-
EV/Sales Ratio	80.05	27.49	92.15	112.08	-	-
Debt / Equity Ratio	0.28	0.16	0.04	0.01	-1.33	-2.93
Asset Turnover	0.02	0.09	0.03	0.05	-	-
Inventory Turnover	0.28	0.66	0.07	1.02	-	-
Quick Ratio	4.68	8.80	8.45	31.55	4.42	6.99
Current Ratio	4.98	9.36	8.72	31.96	4.75	7.24
Return on Equity (ROE)	-24.70%	-11.31%	-8.69%	-305.24%	-	-
Return on Assets (ROA)	-13.19%	-7.32%	-8.65%	-10.09%	-15.67%	-
Return on Capital (ROIC)	-14.63%	-8.26%	-9.52%	-11.15%	-20.89%	-
Earnings Yield	-8.55%	-2.91%	-2.44%	-49.44%	-	-
FCF Yield	-10.29%	-5.12%	-5.39%	-4.91%	-	-
Buyback Yield / Dilution	-0.22%	-0.09%	-62.34%	-139.72%	-	-
Total Shareholder Return	-0.22%	-0.09%	-62.34%	-139.72%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.